Pharma Licensing
Pharma Out-Licensing
OTC / Nutraceutical - Offer
Safe and Effective Herbal product for Vaginitis (White Discharge in Women) available for acquisition | Safe and Effective Herbal product for Vaginitis (White Discharge in Women) available for acquisition |
|
|
|
I have developed a 100% safe herbal
product for the treatment of vaginitis in unmarried, married and pregnant
women. The product is useful in Bacterial Vaginosis as well as Vaginal Candidiasis.
This product code named WH-1 has significant advantages over the currently
available medications such as FAS-3 Kit and Fluconazole which are indicated
only in bacterial or fungal vaginitis respectively. A recent study done by St.
John’s medical college Bangalore, India states: “To conclude, our study
confirms that WH-1 was found to be equally efficacious as standard drugs of
FAS-3 Kit and Fluconazole in mixed infection, nonspecific vaginitis as well as
vaginal candidiasis.
Adverse effects were higher in standard treatment group.
Certain positive findings of the present study with WH-1 were its global
utility in the treatment of Vaginitis caused by multiple pathogens; minor
incidence of adverse drug reactions; increment in lactobacilli count; and 100%
compliance despite longer duration of treatment. There was no biochemical evidence
of side effects with WH-1 regimen. WH-1 can therefore be considered to be an
effective and safe option for treatment of vaginitis”.
The incidence of vaginitis in different cross
sections of population is alarming. It is said that every woman suffers from
Vaginitis at least once in her lifetime. In US it is estimated that 6 million
visits are made every year for treatment and over a billion dollar is spent annually
on both self-treatment and visits to doctor. The market potential is rapidly
increasing, therefore highlighting the need for a new improved approach. I have
already received trade enquiries from distributors from over 12
countries.
Partnering Strategy I am primarily seeking to sell my IPR and Technical Knowhow a Pharma company having worldwide operations. The present research data is sufficient to commercialize the product in India and many other countries but for EU and American market additional validations are required on a larger group of patients. I am prepared to partner with the buyer of my IPR to take the research further. Development status Applied for Indian Patent. Trade mark and trade name have been granted by Government of India, Trademark Registry.
Powered by !JoomlaComment 3.26
3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."Newer news items
Related Items
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| < Prev | Next > |
|---|
Monitoring news at Farmavita.Net
You can easily
monitor all new articles published at Farmavita.Net
. Click on the RSS button and bookmark the main RSS feed of Farmavita.Net. RSS button is located in URL field of your
browser and also at the lower right side of every Farmavita.Net page |